RUBICON ORGANICS INC (ROMJ.CA) Stock Fundamental Analysis

Canada • TSX Venture Exchange • TSX-V:ROMJ • CA78112W1005

0.44 CAD
0 (0%)
Last: Feb 6, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to ROMJ. ROMJ was compared to 33 industry peers in the Pharmaceuticals industry. ROMJ has an excellent profitability rating, but there are some minor concerns on its financial health. ROMJ has both an excellent growth and valuation score. This means it is growing and it is still cheap. This is a rare combination! These ratings would make ROMJ suitable for value and growth investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • In the past year ROMJ was profitable.
  • In the past year ROMJ had a positive cash flow from operations.
  • In the past 5 years ROMJ always reported negative net income.
  • In multiple years ROMJ reported negative operating cash flow during the last 5 years.
ROMJ.CA Yearly Net Income VS EBIT VS OCF VS FCFROMJ.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M -20M

1.2 Ratios

  • ROMJ has a Return On Assets of 4.93%. This is amongst the best in the industry. ROMJ outperforms 81.82% of its industry peers.
  • ROMJ has a Return On Equity of 7.01%. This is amongst the best in the industry. ROMJ outperforms 81.82% of its industry peers.
  • ROMJ's Return On Invested Capital of 23.98% is amongst the best of the industry. ROMJ outperforms 100.00% of its industry peers.
  • ROMJ had an Average Return On Invested Capital over the past 3 years of 19.33%. This is significantly above the industry average of 8.73%.
  • The last Return On Invested Capital (23.98%) for ROMJ is above the 3 year average (19.33%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.93%
ROE 7.01%
ROIC 23.98%
ROA(3y)-4.91%
ROA(5y)-14.11%
ROE(3y)-7.24%
ROE(5y)-22.2%
ROIC(3y)19.33%
ROIC(5y)N/A
ROMJ.CA Yearly ROA, ROE, ROICROMJ.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100

1.3 Margins

  • ROMJ has a Profit Margin of 5.65%. This is in the better half of the industry: ROMJ outperforms 78.79% of its industry peers.
  • The Operating Margin of ROMJ (31.50%) is better than 100.00% of its industry peers.
  • Looking at the Gross Margin, with a value of 64.91%, ROMJ belongs to the top of the industry, outperforming 84.85% of the companies in the same industry.
  • ROMJ's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 31.5%
PM (TTM) 5.65%
GM 64.91%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.88%
GM growth 5YN/A
ROMJ.CA Yearly Profit, Operating, Gross MarginsROMJ.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • ROMJ has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • The number of shares outstanding for ROMJ has been increased compared to 1 year ago.
  • Compared to 5 years ago, ROMJ has more shares outstanding
  • The debt/assets ratio for ROMJ has been reduced compared to a year ago.
ROMJ.CA Yearly Shares OutstandingROMJ.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
ROMJ.CA Yearly Total Debt VS Total AssetsROMJ.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

  • ROMJ has an Altman-Z score of 1.73. This is a bad value and indicates that ROMJ is not financially healthy and even has some risk of bankruptcy.
  • ROMJ's Altman-Z score of 1.73 is amongst the best of the industry. ROMJ outperforms 81.82% of its industry peers.
  • ROMJ has a Debt/Equity ratio of 0.17. This is a healthy value indicating a solid balance between debt and equity.
  • With a decent Debt to Equity ratio value of 0.17, ROMJ is doing good in the industry, outperforming 63.64% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Altman-Z 1.73
ROIC/WACC2.54
WACC9.44%
ROMJ.CA Yearly LT Debt VS Equity VS FCFROMJ.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M 30M

2.3 Liquidity

  • A Current Ratio of 3.10 indicates that ROMJ has no problem at all paying its short term obligations.
  • With a decent Current ratio value of 3.10, ROMJ is doing good in the industry, outperforming 72.73% of the companies in the same industry.
  • A Quick Ratio of 1.33 indicates that ROMJ should not have too much problems paying its short term obligations.
  • The Quick ratio of ROMJ (1.33) is better than 60.61% of its industry peers.
Industry RankSector Rank
Current Ratio 3.1
Quick Ratio 1.33
ROMJ.CA Yearly Current Assets VS Current LiabilitesROMJ.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 228.33% over the past year.
  • The Revenue has grown by 28.55% in the past year. This is a very strong growth!
  • Measured over the past years, ROMJ shows a very strong growth in Revenue. The Revenue has been growing by 29.14% on average per year.
EPS 1Y (TTM)228.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1475.86%
Revenue 1Y (TTM)28.55%
Revenue growth 3Y29.14%
Revenue growth 5YN/A
Sales Q2Q%15.77%

3.2 Future

  • The Earnings Per Share is expected to grow by 80.44% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 21.41% on average over the next years. This is a very strong growth
EPS Next Y216.68%
EPS Next 2Y93.65%
EPS Next 3Y80.44%
EPS Next 5YN/A
Revenue Next Year21.78%
Revenue Next 2Y22.22%
Revenue Next 3Y21.41%
Revenue Next 5YN/A

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ROMJ.CA Yearly Revenue VS EstimatesROMJ.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M
ROMJ.CA Yearly EPS VS EstimatesROMJ.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.1 -0.1 -0.2

More info and screens

Find the best growth stocksShow best growing peers

8

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 8.80 indicates a reasonable valuation of ROMJ.
  • Compared to the rest of the industry, the Price/Earnings ratio of ROMJ indicates a rather cheap valuation: ROMJ is cheaper than 84.85% of the companies listed in the same industry.
  • The average S&P500 Price/Earnings ratio is at 27.92. ROMJ is valued rather cheaply when compared to this.
  • Based on the Price/Forward Earnings ratio of 6.22, the valuation of ROMJ can be described as very cheap.
  • ROMJ's Price/Forward Earnings ratio is rather cheap when compared to the industry. ROMJ is cheaper than 90.91% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 27.78. ROMJ is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 8.8
Fwd PE 6.22
ROMJ.CA Price Earnings VS Forward Price EarningsROMJ.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 100.00% of the companies in the same industry are more expensive than ROMJ, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 1.51
ROMJ.CA Per share dataROMJ.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • ROMJ has a very decent profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as ROMJ's earnings are expected to grow with 80.44% in the coming years.
PEG (NY)0.04
PEG (5Y)N/A
EPS Next 2Y93.65%
EPS Next 3Y80.44%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for ROMJ!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

RUBICON ORGANICS INC

TSX-V:ROMJ (2/6/2026, 7:00:00 PM)

0.44

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-11
Earnings (Next)03-30
Inst Owners3.43%
Inst Owner ChangeN/A
Ins Owners42.68%
Ins Owner ChangeN/A
Market Cap29.56M
Revenue(TTM)57.19M
Net Income(TTM)3.23M
Analysts82.86
Price Target1.17 (165.91%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)345.55%
Min EPS beat(2)-0.99%
Max EPS beat(2)692.08%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)7.42%
Min Revenue beat(2)-0.17%
Max Revenue beat(2)15.01%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)100%
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.84%
Valuation
Industry RankSector Rank
PE 8.8
Fwd PE 6.22
P/S 0.52
P/FCF N/A
P/OCF 11.69
P/B 0.64
P/tB 0.68
EV/EBITDA 1.51
EPS(TTM)0.05
EY11.36%
EPS(NY)0.07
Fwd EY16.07%
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)0.04
OCFY8.55%
SpS0.85
BVpS0.69
TBVpS0.65
PEG (NY)0.04
PEG (5Y)N/A
Graham Number0.88
Profitability
Industry RankSector Rank
ROA 4.93%
ROE 7.01%
ROCE 33.31%
ROIC 23.98%
ROICexc 27.36%
ROICexgc 28.81%
OM 31.5%
PM (TTM) 5.65%
GM 64.91%
FCFM N/A
ROA(3y)-4.91%
ROA(5y)-14.11%
ROE(3y)-7.24%
ROE(5y)-22.2%
ROIC(3y)19.33%
ROIC(5y)N/A
ROICexc(3y)24.75%
ROICexc(5y)N/A
ROICexgc(3y)26.66%
ROICexgc(5y)N/A
ROCE(3y)26.85%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.88%
GM growth 5YN/A
F-Score6
Asset Turnover0.87
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Debt/EBITDA 0.37
Cap/Depr 212.76%
Cap/Sales 12.07%
Interest Coverage 20.97
Cash Conversion 11.9%
Profit Quality N/A
Current Ratio 3.1
Quick Ratio 1.33
Altman-Z 1.73
F-Score6
WACC9.44%
ROIC/WACC2.54
Cap/Depr(3y)93.56%
Cap/Depr(5y)171.69%
Cap/Sales(3y)7.51%
Cap/Sales(5y)22.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)228.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1475.86%
EPS Next Y216.68%
EPS Next 2Y93.65%
EPS Next 3Y80.44%
EPS Next 5YN/A
Revenue 1Y (TTM)28.55%
Revenue growth 3Y29.14%
Revenue growth 5YN/A
Sales Q2Q%15.77%
Revenue Next Year21.78%
Revenue Next 2Y22.22%
Revenue Next 3Y21.41%
Revenue Next 5YN/A
EBIT growth 1Y65.92%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-64.02%
EBIT Next 3Y-0.22%
EBIT Next 5YN/A
FCF growth 1Y-228.39%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-62.76%
OCF growth 3YN/A
OCF growth 5YN/A

RUBICON ORGANICS INC / ROMJ.CA FAQ

What is the fundamental rating for ROMJ stock?

ChartMill assigns a fundamental rating of 6 / 10 to ROMJ.CA.


Can you provide the valuation status for RUBICON ORGANICS INC?

ChartMill assigns a valuation rating of 8 / 10 to RUBICON ORGANICS INC (ROMJ.CA). This can be considered as Undervalued.


Can you provide the profitability details for RUBICON ORGANICS INC?

RUBICON ORGANICS INC (ROMJ.CA) has a profitability rating of 7 / 10.


What is the financial health of RUBICON ORGANICS INC (ROMJ.CA) stock?

The financial health rating of RUBICON ORGANICS INC (ROMJ.CA) is 5 / 10.


What is the earnings growth outlook for RUBICON ORGANICS INC?

The Earnings per Share (EPS) of RUBICON ORGANICS INC (ROMJ.CA) is expected to grow by 216.68% in the next year.